ENXTAM:LKFTBiotechs
Lakefront Biotherapeutics (ENXTAM:LKFT) Stock Reflects Profit Fragility After Revenue Reset
Lakefront Biotherapeutics stock came into this earnings print looking cheap on trailing numbers, trading on a P/E of 2.7x with the share price at €24.34 after a flat week and a soft month. The headline from Q2 is a sharp squeeze in profitability. Net income from ongoing operations dropped to €1.9m with basic EPS of €0.03 while revenue sat at €12.1m. For a biotech that recently swung into profit and still carries a very low multiple, this margin pressure is the flashpoint investors will be...